Evaluating the Effect of Chronic Antihypertensive Therapy on Vasopressor Dosing in Septic Shock
NCT02884011 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133
Last updated 2025-01-03
Summary
Retrospective study to examine the effects of chronic antihypertensive medications on vasopressor dosing in septic shock
Conditions
- Septic Shock
Sponsors & Collaborators
-
Rush University Medical Center
lead OTHER
Principal Investigators
-
Joshua DeMott, Pharm.D. · Rush University Medical Center
-
Ishaq Lat, Pharm.D. · Rush University Medical Center
-
Gourang Patel, Pharm.D. · Rush University Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2017-02-28
- Completion
- 2017-03-31
Countries
- United States
Study Locations
More Related Trials
-
Angiotensin II vs. Vasopressin in Septic Shock
NCT05193370 ·Status: WITHDRAWN ·Phase: PHASE4
-
Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock
NCT00604019 ·Status: COMPLETED ·Phase: PHASE3
-
Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock
NCT00279214 ·Status: COMPLETED ·Phase: PHASE4
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic Shock
NCT04136080 ·Status: UNKNOWN ·Phase: NA
-
NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock
NCT02454348 ·Status: WITHDRAWN ·Phase: PHASE4
-
Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein C
NCT02885168 ·Status: COMPLETED ·Phase: PHASE4
-
Hydrocortisone for Prevention of Septic Shock
NCT00670254 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Vasopressin and Other Pressors in Septic Shock
NCT00269685 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock
NCT05358912 ·Status: COMPLETED ·Phase: PHASE4
-
Initiation of Hydrocortisone for the Treatment of Septic Shock
NCT02580240 ·Status: COMPLETED ·Phase: NA
-
Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic Shock
NCT03014063 ·Status: COMPLETED
-
Relation Between Mean Arterial Pressure and Renal Resistive Index in the Early Phase of Septic Shock
NCT04281277 ·Status: COMPLETED ·Phase: NA
-
Effects of Terlipressin on Renal Perfusion in Patients With Septic Shock
NCT04948372 ·Status: COMPLETED ·Phase: NA
-
Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock
NCT04870892 ·Status: UNKNOWN
-
The Effect of Vasopressor Therapy on Renal Perfusion in Septic Shock
NCT06234592 ·Status: RECRUITING ·Phase: NA
-
The Prognostic Impact of Right Ventricular Systolic Dysfunction on the Survival of Patients With Sepsis and Septic Shock
NCT06193109 ·Status: COMPLETED
-
Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill Cirrhotics
NCT03866083 ·Status: UNKNOWN ·Phase: NA
-
HCT+F vs. HCT Alone in Critically Ill Medical Septic Shock Patients
NCT03710187 ·Status: COMPLETED ·Phase: PHASE2
-
Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock
NCT06746753 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
NCT03434028 ·Status: COMPLETED ·Phase: PHASE3
-
Early Use of Norepinephrine in Septic Shock Resuscitation
NCT01945983 ·Status: COMPLETED ·Phase: NA
-
Continuos Terlipressin Infusion in Septic Shock
NCT01697410 ·Status: UNKNOWN ·Phase: NA
-
Investigating FE 202158 as Potential Primary Treatment in Patients With Early Septic Shock
NCT01612676 ·Status: COMPLETED ·Phase: PHASE2
-
Norepinephrine Exerts an Inotropic Effect at the Early Phase of Human Septic Shock
NCT02750683 ·Status: COMPLETED